A company developing a device to convert pills and capsules into custom-flavored liquids where no liquid alternative is available is raising $3.2 million.
The device will focus on elderly and pediatric patients who have trouble swallowing, such as people with Parkinson’s disease. There is an estimated market of 62 million compounding operations per year in the United States.
The automated device from Patients’ & Consumers’ Pharma in Doylestown, Pennsylvania has a milling function and flavor sachets that can be tailored to individual preferences. It is also developing a computerized variable dosing combination system that will mix several medications for a dosing interval into one or a few capsules.
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The company is initially seeking $500,000 in the first tranche to help Patients’ & Consumers’ Pharma complete its product development and do collaborative testing with local universities. According to its website, it has done collaborations with the College of Engineering, Villanova University and the School of Pharmacy at the University of Wisconsin in Madison.
It also wants to set up a personalized medication products development center that would be a collaboration between the business, local industries and universities. The company is based at the Pennsylvania Biotechnology Center of Bucks County.
Joe D’Silva, the founder and CEO, said: “We’re developing technologies that, in a cost-effective way, will give each person the right medication at the right dose at the right time.”
Joe D’Silva Patients’ & Consumers’ Pharma
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.